醫藥衛生技術(詞匯)標準-分析測試百科網

GB/T 16751.2-2021 中醫臨床診療術語第2部分：證候

本文件共收錄2060個中醫證候名術語（含406個類目詞），并界定其定義。本文件適用于中醫醫療、衛生統計、中醫病案管理、中醫臨床醫療質量評定、科研、教學、出版及國內外學術交流等領域。本文件中具有類目屬性的術語一般不適用于臨床診斷。注：類目屬性的術語是指定義中有“泛指……一類證候”表述方式的術語。

Clinic terminology of traditional Chinese medical diagnosis and treatment—Part 2:Syndromes/patterns

ICS: 01.040.11
CCS: C10
發布: 2021-11-26
實施: 2021-11-26 00:00:00.0

GB/T 13074-2009 血液凈化術語

本標準規定了血液透析、血液濾過、血液透析濾過、腹膜透析、血液灌流和血漿置換等有關的術語。本標準適用于與血液透析、血液濾過、血液透析濾過、腹膜透析、血液灌流和血漿置換有關的科研、設計、生產、維修、管理、教學、臨床等方面。

Terms of blood purification

ICS: 01.040.11
CCS: C45
發布: 2009-05-06
實施: 2010-01-01

GB/T 20348-2006 中醫基礎理論術語

本標準界定了中醫基礎理論中陰陽、五行、臟象、氣血精津液、經絡、體質、病因、病機、養生、預防、治則、五運六氣等的術語。本標準適用于中醫教學、醫療、科學研究、管理、出版及國內學術交流。

Basic theory nomenclature of traditional Chinese medicine

ICS: 01.040.11
CCS: C05
發布: 2006-05-25
實施: 2006-10-01

GB 18469-2001 全血及成分血質量要求

本標準規定了臨床輸注用全血及成分血的質量標準。本標準適用于國內臨床輸注用的全血及成分血。

Standards for whole blood and blood components quality

ICS: 01.040.11
CCS: C50
發布: 2001-10-22
實施: 2002-03-01

GB 18466-2001 醫療機構污水排放要求

1.1 本標準規定了醫療機構污水和污泥的排放標準。 1.2 本標準適用于下列醫療機構： 1）污水直接排入江、河、湖、海、池塘、水庫、溪溝等地表水體的醫療機構。 2）污水直接排入終端無污水處理廠的下水管道的醫療機構。 3）污水無組織排放的醫療機構。 4）所有的傳染病河結核病醫療機構。

Requirements for medical organization sewage discharge

ICS: 01.040.11
CCS: C51
發布: 2001-10-22
實施: 2002-03-01

GB 18467-2001 獻血者健康檢查要求

本標準規定了獻血者體格檢查和血液檢驗的項目和要求。本標準適用于全國各級血站（血庫），并用于該機構的管理和評審。

Health examination criteria of blood donors

ICS: 01.040.11
CCS: C50
發布: 2001-10-22
實施: 2002-03-01

GB/T 17857-1999 醫用放射學術語(放射治療、核醫學和輻射劑量學設備)

本標準規定了醫用放射學基礎、放射治療設備、核醫學設備、輻射劑量學設備的術語和定義。本標準適用于放射治療、核醫學及其劑量測量專業領域內從事科研、生產、監督檢驗和臨床應用等方面的技術人員使用。

Medical radiology--Terminology(Equipment for radiotherapy,nuclear medicine and radiation dosimetry)

ICS: 01.040.11
CCS: C30
發布: 1999-09-19
實施: 2000-01-01

DB41/T 2777-2024 成年人健康風險評估規范

Guidelines for Adult Health Risk Assessment

ICS: 01.040.11
CCS: C 00/09
發布: 2024-11-07
實施: 2025-02-06

1.1 This terminology defines basic terms and presents the relationships of the scientific fields related to Tissue Engineered Medical Products (TEMPs). Committee F04 has defined these terms for the specific purpose of unifying the language used in standards for TEMPs. 1.2 The terms and relationships defined here are limited to TEMPs. They do not apply to any medical products of human origin regulated by the U.S. Food and Drug Administration under 21 CFR Parts 16 and 21 CFR Parts 207, 807, and 1271. 1.3 The terms and nomenclature presented in this standard are for the specific purposes of unifying the language used in TEMP standards and are not intended for labeling of regulated medical products. 1.4 This standard does not purport to address all of the safety concerns, if any, associated with its use. It is the responsibility of the user of this standard to establish appropriate safety, health, and environmental practices and determine the applicability of regulatory limitations prior to use. 1.5 This international standard was developed in accordance with internationally recognized principles on standardization established in the Decision on Principles for the Development of International Standards, Guides and Recommendations issued by the World Trade Organization Technical Barriers to Trade (TBT) Committee.

Standard Terminology Relating to Tissue Engineered Medical Products